approval
saveKESIMPTA (OFATUMUMAB) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalKESIMPTA (OFATUMUMAB) — FDA approvalApr 1, 2026 · 188d ago
- approvalKESIMPTA (OFATUMUMAB) — FDA approvalApr 12, 2024 · 907d ago
- approvalKESIMPTA (OFATUMUMAB) — FDA approvalJan 19, 2024 · 991d ago
- approvalKESIMPTA (OFATUMUMAB) — FDA approvalSep 2, 2022 · 1495d ago
- approvalKESIMPTA (OFATUMUMAB) — FDA approvalAug 20, 2020 · 2238d ago
- approvalKESIMPTA (OFATUMUMAB) — FDA approvalAug 30, 2016 · 3689d ago
- approvalKESIMPTA (OFATUMUMAB) — FDA approvalJan 19, 2016 · 3913d ago
- approvalKESIMPTA (OFATUMUMAB) — FDA approvalApr 17, 2014 · 4555d ago
same company · ±60 days · 6
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalAug 6, 2025
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalAug 6, 2025
- approvalinclisiran: LEQVIO (INCLISIRAN SODIUM) — FDA approvalJul 31, 2025
- approvalOXCARBAZEPINE: TRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 23, 2025
- approvalOXCARBAZEPINE: TRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 23, 2025
- approvalremibrutinib: RHAPSIDO (REMIBRUTINIB) — FDA approvalSep 30, 2025
comments(0)
5-min edit window · permanent after that